Enbezotinib |
رقم الكتالوجGC65354 |
يمكن أن يثبط Enbezotinib ، وهو مثبط لـ RET ، الفسفرة الذاتية RETيمكن استخدام Enbezotinib لأبحاث السرطان
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2359649-81-1
Sample solution is provided at 25 µL, 10mM.
Enbezotinib, an inhibitor of RET, can inhibit the RET autophosphorylation. Enbezotinib can be used for the research of cancer[1].
Enbezotinib (compound 5) (0.3-300 nM) inhibits p-RET (y905) in RET-driven cells[1].
Enbezotinib (compound 5) (2-5 mg/kg; twice daily for 27 days) decreases tumor size in mice[1].
[1]. ROGERS EW, et, al. Macrocyclic compounds for treating disease. WO2019126121A1.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *